The mechanism of cancer-depression comorbidity
Authors:
- 1 August 2024
- journal article
- review article
- Published by Elsevier in Neuroscience
- Vol. 556, 25-30
Abstract
No abstract availableKeywords
Funding Information
- Foundation for Innovation Groups of Basic Research in Gansu Province (2018B0303110014, 2020B090924004)
- Key Program of NSFC-Tongyong Union Foundation (82003730)
- Basic and Applied Basic Research Foundation of Guangdong Province
- Youth Science Fund Project
- National Natural Science Foundation of China
This publication has 73 references indexed in Scilit:
- Association of Second-generation Antiandrogens With Depression Among Patients With Prostate CancerJAMA Network Open, 2021
- Long‐term depression incidence and associated mortality among African American and White prostate cancer survivorsCancer, 2021
- Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findingsCancer, 2020
- Prevalence and predictors of probable depression in prostate cancer survivorsCancer, 2019
- Dispositional mindfulness, self‐compassion, and compassion from others as moderators between stress and depression in caregivers of patients with lung cancerPsycho-Oncology, 2019
- Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patientsPsycho-Oncology, 2019
- Lung cancer stigma and depression: Validation of the Lung Cancer Stigma InventoryPsycho-Oncology, 2019
- Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapyCancer, 2019
- C‐reactive protein and its association with depression in patients receiving treatment for metastatic lung cancerCancer, 2018
- Depression treatment and healthcare expenditures among elderly Medicare beneficiaries with newly diagnosed depression and incident breast, colorectal, or prostate cancerPsycho-Oncology, 2016